Developing A Multi-Drug Antiparasitic For Dogs

Formulating multiple active ingredients into a single, palatable dose for canine parasitic infections requires more than standard formulation — it demands careful balance across chemistry, delivery, and manufacturability. The challenge lies in maintaining stability at high drug loads, improving solubility for poorly water-soluble compounds, and ensuring strong taste acceptance for consistent dosing.

A structured development approach was applied, combining compatibility studies, iterative prototype refinement, pH optimization, and targeted stability assessments to address these competing requirements. Each step helped refine the formulation toward a more robust and practical solution.

The outcome is a scalable manufacturing approach that delivers consistent quality, reliable drug release, and strong palatability across multiple strengths, along with matching placebos produced within accelerated timelines. This work demonstrates how integrated formulation strategies can simplify complexity while meeting stringent veterinary standards.

Explore how these approaches can support the development of your next complex combination product.